Product Information
RAPAFLO 8 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $8.3953 per EA under NDC 00023614230. Its NADAC has been published 389 times since Jul 11, 2018.
The High Outlier badge above means this manufacturer's average price in the silodosin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Allergan, Inc.NDC
00023614230
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
3/18/2026
Active Ingredients
SILODOSINApproval Type
New Drug (NDA)
FDA Application
NDA022206On Market Since
3/23/2009
Pharmacological Classes
Price Statistics
The NADAC for RAPAFLO 8 MG CAPSULE has been published 389 times since Jul 11, 2018, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3953 per EA |
|---|---|
| All-time high | $8.4257 (Jul 12, 2023) |
| All-time low | $7.9248 (Jul 11, 2018) |
| 52-week high | $8.4101 |
| 52-week low | $8.3895 |
| Median price | $8.3686 |
| Average price | $8.3526 |
| Largest weekly change | +4.9% (Jan 9, 2019) |
| Weeks tracked | 389 |
| Tracking since | Jul 11, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the silodosin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RAPAFLO 8 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAPAFLO 8 MG CAPSULE, manufactured by Allergan, Inc., is $8.3953 per EA (NDC 00023614230), effective May 20, 2026.
How has the price of RAPAFLO 8 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAPAFLO 8 MG CAPSULE has risen 5.9%. It has been tracked across 389 weekly CMS publications since Jul 11, 2018.
What are the highest and lowest recorded NADAC prices for RAPAFLO 8 MG CAPSULE?
Since Jul 11, 2018, the NADAC for RAPAFLO 8 MG CAPSULE has ranged from a low of $7.9248 (Jul 11, 2018) to a high of $8.4257 (Jul 12, 2023), with a median of $8.3686 per EA.
Are there cheaper alternatives to RAPAFLO 8 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RAPAFLO 8 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures RAPAFLO 8 MG CAPSULE?
RAPAFLO 8 MG CAPSULE (NDC 00023614230) is labeled by Allergan, Inc., and CMS classifies it as a brand product.